DeepMed Research

The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer
Periampullary Adenocarcinoma

Interventions: Drug: capecitabine
Drug: vorinostat
Radiation: Radiotherapy
Procedure: Surgery to remove tumor

First Posted Date: 2009-09-24

Last Posted Date: 2015-06-15

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 21

Registration Number: NCT00983268

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Terminated

Conditions: Cancer

Interventions: Genetic: polymorphism analysis
Other: laboratory biomarker analysis

First Posted Date: 2009-08-12

Last Posted Date: 2013-05-14

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 252

Registration Number: NCT00957736

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Terminated

Conditions: Cancer

First Posted Date: 2009-07-30

Last Posted Date: 2018-08-16

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 1000

Registration Number: NCT00949052

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: cisplatin
Drug: everolimus
Drug: paclitaxel
Other: placebo
Procedure: Venous blood draw

First Posted Date: 2009-07-02

Last Posted Date: 2015-05-07

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 145

Registration Number: NCT00930930

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸
The Methodist Hospital Research Institute, Houston, Texas, United States

and more 5 locations

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: laboratory biomarker analysis
Other: medical chart review

First Posted Date: 2009-05-12

Last Posted Date: 2018-05-04

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 26

Registration Number: NCT00897468

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202

Completed

Conditions: Solid Tumor
Lymphoma

First Posted Date: 2009-05-12

Last Posted Date: 2016-04-25

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 9

Registration Number: NCT00896662

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Completed

Conditions: Healthy, no Evidence of Disease
Lung Cancer

Interventions: Genetic: proteomic profiling
Other: biologic sample preservation procedure
Other: laboratory biomarker analysis
Procedure: bronchoscopy

First Posted Date: 2009-05-12

Last Posted Date: 2014-06-24

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 37

Registration Number: NCT00899457

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

Terminated

Conditions: Lung Cancer

Interventions: Genetic: protein expression analysis
Genetic: proteomic profiling
Other: biologic sample preservation procedure
Other: laboratory biomarker analysis
Other: matrix-asst laser desorption/ionization time flight mass spectrometry
Other: questionnaire administration

First Posted Date: 2009-05-12

Last Posted Date: 2014-06-24

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 564

Registration Number: NCT00898209

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Completed

Conditions: Gestational Trophoblastic Tumor
Ovarian Cancer
Testicular Germ Cell Tumor
Breast Cancer
Leukemia
Myelodysplastic Syndromes
Neuroblastoma
Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Lymphoma

Interventions: Genetic: gene expression analysis
Genetic: microarray analysis
Genetic: polymorphism analysis
Genetic: proteomic profiling
Other: flow cytometry
Other: immunologic technique
Other: laboratory biomarker analysis
Procedure: biopsy

First Posted Date: 2009-05-12

Last Posted Date: 2012-11-06

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 190

Registration Number: NCT00900406

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States

Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer

Terminated

Conditions: Solid Tumor

First Posted Date: 2009-05-12

Last Posted Date: 2013-01-29

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 10

Registration Number: NCT00898027

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy